Evidence map›Paper›PMID 34988174›Full record

ArticleAnnals of translational medicine2021

Radiomic signatures based on multiparametric MR images for predicting Ki-67 index expression in medulloblastoma.

Lili Zhou, Hong Peng, Qiang Ji, Bo Li, Lexin Pan, Feng Chen, Zishan Jiao, Yali Wang, Mengqian Huang, Gaifen Liu and 2 more

Abstract read
In one paragraph

Article in Annals of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Radiomic- and dosiomic-based clustering development for radio-induced neurotoxicity in pediatric medulloblastoma.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lili ZhouCancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Hong PengDepartment of Radiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qiang JiCancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Bo LiDepartment of Radiology, Xiangtan Central Hospital, Xiangtan, China.
Lexin PanSchool of Mechatronical Engineering, Beijing Institute of Technology, Beijing, China.
Feng ChenCancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Zishan JiaoCapital Medical University, Beijing, China.
Yali WangCancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Mengqian HuangCancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Gaifen LiuBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yaou LiuDepartment of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wenbin LiCancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedulloblastoma (MB) is a common central nervous system tumor in children with extensive heterogeneity and different prognoses. This study aimed to classify the Ki-67 index in MB with radiomic characteristics based on multi-parametric magnetic resonance imaging to guide treatment and assess the prognosis of patients.

methodsThree sequences of T1W, CE-T1W, and T2W were used as test data. Two experienced radiologists manually segmented the tumors according to T2W images from 90 patients. The patients were divided into training and test sets at a ratio of 7:3, and 833 dimensional image features were extracted for each patient. Five models were trained using the feature set selected in three ways. Finally, the area under the curve (AUC) and accuracy (ACC) were used on the test set to evaluate the performance of the different models.

resultsA random forest (RF) model combining three sequence features achieved the best performance (ACC: 0.771, 95% CI: 0.727 to 0.816; AUC: 0.697, 95% CI: 0.614 to 0.78). The voting model that combined a RF and a support vector machine (SVM) had higher performance than the other models (ACC: 0.796, 95% CI: 0.76 to 0.833; AUC: 0.689, 95% CI: 0.615 to 0.763). The best prediction model that used only one sequence feature was voting in the T2W sequence (ACC: 0.736, 95% CI: 0.705 to 0.766; AUC: 0.636, 95% CI: 0.585 to 0.688). The ensemble model was better than the single training model, and a multi-sequence combination was better than a single sequence prediction. The multiple feature selection methods were better than a combination of the two methods.

conclusionsA model obtained by machine learning could help doctors predict the Ki-67 values of patients more efficiently to make targeted judgments for subsequent treatments.

Indexed as

Ki-67 indexMedulloblastoma (MB)radiomics

Identifiers

PMID34988174
PMCPMC8667089

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.